Less inflammation: Semaglutide reduces inflammation throughout the body
Is the long-term safety of GLP-1 medications considered favorable
Right now, Im on CJC-1295 and retatrutide
If someone has both lupus and diabetes, the kidneys may be at risk from more than one direction
Who Should Not Switch Patients with active or recent pancreatitis, personal or family history of medullary thyroid carcinoma (MTC), or multiple endocrine neoplasia type 2 (MEN2) should not be initiated on any GLP-1 receptor agonist, including retatrutide [4]
This guide covers all of them, with specific timelines, dose protocols, safety data, and the practical realities of using GLP-1 medications while navigating the most demanding period of your life